In addition, the weak or absent synchrony of IL-3 levels with thelevels of other classically studied biomarkers, as well as with the severity scoresvalues, and the absence of associations between IL-3 levels and the secondaryoutcomes, indicate the need for further investigations of the behavior and utilityof this cytokine in sepsis patients. The gene discussed is IL3; the disease is Sepsis.